|
1
|
Obeid M, Tesniere A, Ghiringhelli F, Fimia
GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T,
Casares N, et al: Calreticulin exposure dictates the immunogenicity
of cancer cell death. Nat Med. 13:54–61. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Obeid M, Tesniere A, Panaretakis T, Tufi
R, Joza N, van Endert P, Ghiringhelli F, Apetoh L, Chaput N,
Flament C, et al: Ecto-calreticulin in immunogenic chemotherapy.
Immunol Rev. 220:22–34. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ahn YH, Hong SO, Kim JH, Noh KH, Song KH,
Lee YH, Jeon JH, Kim DW, Seo JH and Kim TW: The siRNA cocktail
targeting interleukin 10 receptor and transforming growth factor-β
receptor on dendritic cells potentiates tumour antigen-specific
CD8(+) T cell immunity. Clin Exp Immunol. 181:164–178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steinman RM, Hawiger D and Nussenzweig MC:
Tolerogenic dendritic cells. Annu Rev Immunol. 21:685–711. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen L: Co-inhibitory molecules of the
B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol.
4:336–347. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hodi FS, Mihm MC, Soiffer RJ, Haluska FG,
Butler M, Seiden MV, Davis T, Henry-Spires R, MacRae S, Willman A,
et al: Biologic activity of cytotoxic T lymphocyte-associated
antigen 4 antibody blockade in previously vaccinated metastatic
melanoma and ovarian carcinoma patients. Pro Natl Acad Sci USA.
100:4712–4717. 2003. View Article : Google Scholar
|
|
7
|
Wang J, Gao ZP, Qin S, Liu CB and Zou LL:
Calreticulin is an effective immunologic adjuvant to tumor
associate antigen. Exp Ther Med. 14:3399–3406. 2017.PubMed/NCBI
|
|
8
|
Demaria O, Gassart A, Coso S, Gestermann
N, Di Domizio J, Flatz L, Gaide O, Michielin O, Hwu P, Petrova TV,
et al: STING activation of tumor endothelial cells initiates
spontaneous and therapeutic antitumor immunity. Proc Natl Acad Sci
USA. 112:pp. 15408–15413. 2015; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ghosh S, Sarkar M, Ghosh T, Guha I,
Bhuniya A, Saha A, Dasgupta S, Batik S, Bose A and Baral R: Neem
leaf glycoprotein promotes dual generation of central and effector
memory CD8(+) T cells against sarcoma antigen vaccine to induce
protective anti-tumor immunity. Mol Immunol. 71:42–53. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gardai SJ, McPhilips KA, Frasch SC,
Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg
PA, Michalak M and Henson PM: Cell-surface calreticulin initiates
clearance of viable or apoptotic cells through trans-activation of
LRP on the phagocyte. Cell. 123:321–334. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen L, Evel-Kabler K, Strube R and Chen
SY: Silencing of SOCS1 enhances antigen presentation by dendritic
cells and antigen-specific anti-tumor immunity. Nat Biotechnol.
22:1546–1553. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim JH, Kang TH, Noh KH, Kim SH, Lee YH,
Kim KW, Bae HC, Ahn YH, Choi EY, Kim JS, et al: Enhancement of DC
vaccine potency by activating the PI3K/AKT pathway with a small
interfering RNA targeting PTEN. Immunol Lett. 134:47–54. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim JH, Kang TH, Noh KH, Bae HC, Ahn YH,
Lee YH, Choi EY, Chun KH, Lee SJ and Kim TW: Blocking the
immunosuppressive axis with small interfering RNA targeting
interleukin (IL)-10 receptor enhances dendritic cell-based vaccine
potency. Clin Exp Immunol. 165:180–189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang H, Ma JL, Yang YG, Song Y, Wu J, Qin
YY, Zhao XL, Wang J, Zou LL, Wu JF, et al: Efficient therapeutic
delivery by a novel cell-permeant peptide derived from KDM44
protein for antitumor and antifibrosis. Oncotarget. 7:49075–49090.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eguchi A, Meade BR, Chang YC, Fredrickson
CT, Willert K, Puri N and Dowdy SF: Efficient siRNA delivery into
primary cells by a peptide transduction domain-ds RNA binding
domain fusion protein. Nat Biotechnol. 27:567–571. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang H, Li S, Li F, Yu K, Yang F and Xiang
J: Recombinant expression of a modified shrimp
anti-lipopolysaccharide factor gene in Pichia pastoris GS115 and
its characteristic analysis. Mar Drugs. 14:E1522016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hanada T, Yoshida H, Kato S, Tanaka K,
Masutani K, Tsukada J, Nomura Y, Mimata H, Kubo M and Yoshimura A:
Suppressor of cytokine signaling-1 is essential for suppressing
dendritic cell activation and system autoimmunity. Immunity.
19:437–450. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar A, Kundu S and Debnath DM:
Expression, purification and evaluation of recombinant lipoprotein
of Salmonella typhi as a vaccine candidate. Biologicals.
46:108–113. 2017. View Article : Google Scholar : PubMed/NCBI
|
